| Name: | Ezetimibe Impurity D |
| Catalogue No. | VL203024 |
| CAS No. | N/A |
| Molecular Formula | C39H46F2N2O5Si2 |
| Molecular Weight | 716.96 |
| Status | In-stock |
| IUPAC Name | (S)-3-((2R,5S)-5-(4-Fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-((trimethylsilyl)oxy)phenyl)methyl)5-((trimethylsilyl)oxy)pentanoyl)-4-phenyloxazolidin-2-one |
| Appearance | Off White powder |
| Description | Ezetimibe Impurity D or (S)-3-((2R,5S)-5-(4-Fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-((trimethylsilyl)oxy)phenyl)methyl)5-((trimethylsilyl)oxy)pentanoyl)-4-phenyloxazolidin-2-one is associate impurity of Ezetimibe. Ezetimibe is used as an adjunctive therapy to a healthy diet to lower cholesterol levels in primary hyperlipidemia, mixed hyperlipidemia, homozygous familial hypercholesterolemia , and homozygous sitosterolemia |
| References | “Sci-Hub | Ezetimibe | 10.2165/00129784-200303010-00007.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.2165/00129784-200303010-00007. |
